Lloyd Hancock
Endocrinology, Diabetes & Metabolism · Murfreesboro, TNNPI 1083655518
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 45.4% of the total. Reporting peaked in 2019 at $10,967 and has fallen 95.0% since, to $551 in 2022.
Across 294 payments — averaging $64.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$9K
- Lilly USA, LLC$5K
- Boehringer Ingelheim$2K
- Novo Nordisk$552
- AstraZeneca$502
- Corcept Therapeutics$388
- plus $2K from 23 others
What the payments were for
- Consulting fees$3,25017%
- Speaking & faculty fees$9,32949%
- Travel & lodging$2,03911%
- Food & beverage$4,37823%
- Education$1061%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 32 | $8,680 |
| Lilly USA, LLC | 68 | $5,446 |
| Boehringer Ingelheim | 6 | $2,031 |
| Novo Nordisk | 40 | $552 |
| AstraZeneca | 29 | $502 |
| Corcept Therapeutics | 21 | $388 |
| AbbVie | 12 | $196 |
| Insulet Corporation | 14 | $175 |
| Amarin Pharma, Inc. | 8 | $120 |
| Merck | 8 | $114 |
| Medtronic(2 entities) | 6 | $110 |
| Abbott | 7 | $92 |
| Xeris Pharmaceuticals, Inc. | 4 | $89 |
| Lifescan, Inc. | 4 | $71 |
| IBSA Pharma Inc. | 5 | $71 |
| Shire North American Group Inc | 5 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $66 |
| Dexcom, Inc. | 4 | $63 |
| Amgen(2 entities) | 4 | $57 |
| Tandem Diabetes Care, Inc. | 1 | $40 |
| Nalpropion Pharmaceuticals LLC | 2 | $33 |
| Companion Medical, Inc. | 2 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
| Valeritas, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| GSK | 1 | $14 |
| Vistapharm, Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIQUA 100/33$5,474
- TOUJEO$2,721
- JARDIANCE$1,950
How this compares
$19,102 in reported general payments places this provider in the 75th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Other endocrinology, diabetes & metabolism in Murfreesboro
- Christopher AlbergoMurfreesboro$9K
- James RoneMurfreesboro$6K
- Alan CohenMemphis$1.4M
- Craig WierumNashville$1.3M
- Pascal DauphinHendersonville$925K
- Shimon HararyMemphis$735K
- Lisa MyersGermantown$609K
- Amit VoraKnoxville$579K
- Terri JerkinsNashville$567K
- Samuel Dagogo-JackMemphis$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.